What’s New in Intra-Arterial Chemotherapy for Retinoblastoma?
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Ophthalmology
Reference33 articles.
1. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results;Abramson;Ophthalmology,2008
2. Chemosurgery for retinoblastoma: what we know after 5 years;Abramson;Arch Ophthalmol,2011
3. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience;Gobin;Arch Ophthalmol,2011
4. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis;Suzuki;Ophthalmology,2011
5. Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization;Klufas;AJNR Am J Neuroradiol,2012
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. What have we learnt about intraarterial chemotherapy (Ophthalmic Artery Chemosurgery) for retinoblastoma in the past 18 years? The third A. Linn Murphree Lecture;Ophthalmic Genetics;2024-09-04
2. Advancements in super-selective catheterization and drug selection for intra-arterial chemotherapy for retinoblastoma: a 15-year evolution;Journal of NeuroInterventional Surgery;2023-05-17
3. Re: Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. High-risk pathologic features based on presenting findings in advanced intraocular retinoblastoma: a multicenter, international data-sharing American Joint Committee on Cancer Study (Ophthalmology. 2022;129:923–932) and Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. Metastatic death based on presenting features and treatment for advanced intraocular retinoblastoma: a multicenter registry-based study. (Ophthalmology. 2022;129:933–945);Ophthalmology;2023-03
4. Retinoblastoma: From genes to patient care;European Journal of Medical Genetics;2023-01
5. Health-Related Quality of Life in Adolescent and Young Adult Retinoblastoma Survivors;Journal of Pediatric Hematology/Oncology Nursing;2022-06-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3